DrugPatentWatch Database Preview
Patent: 10,081,681
» See Plans and Pricing
Summary for Patent: 10,081,681
| Title: | Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors |
| Abstract: | Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody. |
| Inventor(s): | Korman; Alan J. (Piedmont, CA), Lonberg; Nils (Woodside, CA), Fontana; David J. (Clyde Hill, WA), Gutierrez; Andres A. (Lawrenceville, NJ), Selby; Mark J. (San Francisco, CA), Lewis; Katherine E. (Lake Forest Park, WA) |
| Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
| Application Number: | 15/021,102 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,081,681
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | Start Trial | Bristol-Myers Squibb Company (Princeton, NJ) | 2033-09-20 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,081,681
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2014323523 | Start Trial |
| Canada | 2924524 | Start Trial |
| China | 105793287 | Start Trial |
| Denmark | 3178849 | Start Trial |
| Eurasian Patent Organization | 201690617 | Start Trial |
| European Patent Office | 3046939 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
